Glutathione for Skin: What the Research Has Looked At, and What It Has Not

Pepti supplies Glutathione as a 5 mL vial at 200 mg/mL (1,000 mg per vial) for $199/mo, all-in, and does not prescribe it for skin lightening.

Glutathione is a tripeptide made of three amino acids, glutamate, cysteine and glycine, and every nucleated cell makes it. It is the most abundant small thiol in the body and the main antioxidant inside cells. The active form is reduced glutathione (GSH); when it neutralizes a reactive molecule it becomes glutathione disulfide (GSSG), and an enzyme recycles it using NADPH. The GSH to GSSG ratio is a standard laboratory measure of oxidative stress. Glutathione does not bind a receptor, so for skin, as for everything else, the question is whether giving more from outside changes anything, and by which route. The full reference is what is glutathione.

Skin color comes largely from melanin, made in pigment cells. Two broad types matter here: eumelanin, which is dark brown to black, and pheomelanin, which is lighter, red to yellow. The rate-limiting enzyme in making melanin is tyrosinase.

The pigmentation research rests on two proposed actions, both laid out in a 2016 review in the Indian Journal of Dermatology, Venereology and Leprology:

Glutathione's general role as an antioxidant is also why it comes up in conversations about skin and oxidative stress. These are descriptions of mechanism. A mechanism explains why researchers ran the trials below; it is not evidence that taking glutathione by any route changes skin.

Three small randomized trials exist, all in healthy volunteers. None ran longer than three months.

How to read them

The measure was a number, not an outcome people chose. Melanin index is an instrument reading of skin pigment. A change in melanin index at some sites is a laboratory-style finding, not a measure of whether a person saw or valued a difference.

The results were partial. In the 2012 trial the change beat placebo at two of six sites, which means it did not at the other four. In the 2017 trial, melanin index "tended" lower, wording that signals a trend rather than a clear separation from placebo.

The groups were narrow. Medical students and healthy women, not people with a pigment condition. None of the trials studied melasma, acne, dark spots, scarring or any other skin disease.

The routes were oral and topical. No trial used an injection under the skin, and none used an IV.

They were short. Four to twelve weeks. Nothing in them says whether any change persists, and the one long oral glutathione trial, which measured body stores rather than skin, found levels back at baseline within a month of stopping (European Journal of Nutrition, 2015).

Glutathione injections and IV drips are widely marketed for skin. The research does not support that marketing.

Subcutaneous injection. There are no randomized controlled trials of subcutaneous glutathione for any purpose, skin included. Whether a small injection under the skin raises glutathione in tissue has not been measured.

IV glutathione. The 2016 review states that intravenous glutathione for skin lightening has no controlled evidence. What is known about IV glutathione comes from other uses: a 1995 trial in people receiving cisplatin chemotherapy reported less nerve damage, and a 2009 randomized trial in Parkinson's disease found no difference from placebo. A 1991 study found high-dose IV glutathione rose sharply in plasma and cleared within minutes to an hour. None of that is skin research.

An ingredient warning. On 7 June 2019 the FDA warned compounders about a dietary-supplement-grade glutathione powder from one repackager that had been used to make intravenous injections. Testing found bacterial endotoxin at up to five times the appropriate limit, and eight patients had reactions ranging from chills and nausea to low blood pressure and hospitalization. The problem was the ingredient, not glutathione, and it is the reason a sterile injectable must come from a pharmacy accountable for endotoxin testing. It is also a reason to be wary of skin-lightening drips whose ingredients are not documented.

• That glutathione by any route changes skin tone in a way people would notice. The trials measured melanin index and found modest, partial changes.
• Any effect of injected or IV glutathione on skin. There are no controlled trials.
• Any effect on a skin condition, such as melasma, acne, dark spots or scarring. None was studied.
• Whether any change lasts beyond three months, or what happens after stopping.
• The safety of long-term, high-dose use for skin purposes.
• Efficacy for any condition as an FDA-approved treatment. Glutathione injection is not an FDA-approved drug product.

Pepti prescribes glutathione injections, but not for skin lightening and not for any skin result. The reasons are the ones above: the only skin trials are oral and topical, small and short, with partial results; there is no controlled evidence for the injection or the IV route; and a skin-lightening promise would be a claim the research does not make. If skin is the reason for the conversation, expect your physician to say so plainly.

When glutathione is prescribed at Pepti, it is as a compounded injection for antioxidant support, reviewed against your history. The research on that, benefit by benefit and route by route, is in glutathione benefits, and the oral and liposomal comparison is in liposomal glutathione vs injectable.

GHK-Cu ($239/mo) is described around collagen and matrix signalling rather than pigment, and its human data is topical; the injectable has no human trials. The KLOW blend ($259/mo) contains it. Neither is a pigment treatment.

Glutathione has an unusually deep tolerability record for a compounded injectable: the 2009 intravenous trial reported adverse events similar to placebo at 1,400 mg three times weekly, and the six-month oral trial reported no safety signal.

Glutathione is not used in pregnancy or breastfeeding, where safety data is absent. It is a cofactor in the metabolism of many drugs, and there is no established interaction list for the subcutaneous route, so list everything you take. The injection goes into the fat layer and must never be injected into a vein.

As of the FDA's document dated 14 May 2026, glutathione is in 503A Category 1, "Bulk Drug Substances Under Evaluation," under which state-licensed pharmacies may compound it while the FDA completes its review. It was never in Category 2, the safety-concern category. It is also in Category 1 of the separate 503B list dated 21 March 2025. Compounded glutathione is not FDA approved, and no form of glutathione is approved for skin.

The price covers medication, physician review, refill management and shipping, with no membership fee, and Pepti does not bill insurance. Your physician sets your directions after reviewing your intake, and they are printed on the vial. Refills run every 28 days, one vial per fill. The vial ships refrigerated with ice packs, ready to use, with sterile syringes and alcohol prep pads. Lot test results are at /quality/lab-results.

Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.

1. Complete a free online intake covering your history, medications and what you want help with.
2. A physician licensed in your state reviews it, usually within 24 hours.
3. If it is appropriate, a PCAB-accredited, FDA-registered US 503A pharmacy compounds it to that prescription. Lot test results are published at /quality/lab-results.
4. It ships refrigerated with your directions printed on the vial.
5. Your physician stays reachable for questions and dose changes.

Pepti prescribes glutathione in every state except Oklahoma, plus DC, not for skin lightening. Step by step: how to get glutathione prescribed online.